Evaluation of prescribing quality in nursing homes based on drug-specific indicators: The Bergen district nursing home (BEDNURS) study

Norsk Epidemiologi

Volumn 18, Issue 2, 2008, Pages 173-178

  Ruths, Sabine ^a,b  

^a Research Unit for General Practice   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DICLOFENAC; ESTROGEN; FLUNITRAZEPAM; HYDROXYZINE; HYPNOTIC AGENT; INDOMETACIN; LAXATIVE; LOOP DIURETIC AGENT; MIDAZOLAM; NITRAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PSYCHOTROPIC AGENT; SPASMOLYTIC AGENT; SULINDAC; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

AGED; ARTICLE; DRUG INDICATION; EVALUATION; FEMALE; GOOD CLINICAL PRACTICE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; NURSING HOME; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PATIENT CARE; POLYPHARMACY; PREDICTOR VARIABLE; PRESCRIPTION; QUALITY CONTROL; RISK ASSESSMENT;

EID: 45549100104     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Statistics Norway. http://www.ssb.no (accessed 30.12.2007).
2. Engedal K, Haugen PK. The prevalence of dementia in a sample of elderly Norwegians. Int J Geriatr Psychiatry 1993; 8: 565-570.
3. Jano E, Aparasu RR. Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother 2007; 41: 438-447.
4. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-1536.
5. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
6. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94.
7. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051.
8. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen district nursing home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176-180.
9. Socialstyrelsen [Swedish National Board of Health and Welfare]. Indicators for evaluation of the quality of drug therapy among elderly. Report 2003-110-20. http://www.socialsryrelsen.se/NR/rdonlyres/A65367AB-8F2A-4063-BC79- 13103784A838/986/200311020.pdf (accessed 30.12.2007).
10. World Health Organisation. ATC Index with DDDs and Guidelines for ATC classification and DDD assignment, 2005. http://www.who.org (accessed 30.12.2007).
11. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. Study protocol: A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice - The prescription peer academic detailing (Rx-PAD) study. BMJ Health Services Research 2006; 6: 72 http://www.biomedcentral.eom/1472-6963/6/72 (11.01.08).
12. McLeod PJ. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385-391.
13. van Dijk KN, Pont LG, de Vries CS, Franken M, Brouwers RJ, de Jong-van den Berg LT. Prescribing indicators for evaluating drug use in nursing homes. Ann Pharmacother 2003; 37: 1136-1141.
14. DRUID (Drug Information Database) http://www.interaksjoner.no/ (accessed 10.01.08).
15. Roberts MS, King M, Stokes JA, Lynne TA, Bonner CJ, McCarthy S, et al. Medication prescribing and administration in nursing homes. Age Ageing 1998; 27: 385-392.
16. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195-204.
17. Bergman Å, Olsson J, Carlsten A, Waern M, Fastbom J. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 2007; 25: 9-14.
18. Gupta G, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996; 18: 183-196.
19. Dhalla IA, Anderson GM, Mamdani MM, Bronskill SE, Sykora K, Rochon PA. Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 2002; 50: 995-1000.
20. Landi F, Russo A, Liperoti R, Cesari M, Barillaro C, Pahor M, Bernabei R, Onder G. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007; 81: 235-241.
21. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2006; 63: 187-195.
22. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177-186.